Drug guidance
Ferric carboxymaltose for treating iron deficiency anaemia
Condition
Blood and Immune System
2 January 2024
Published on 02 Sep 2019
Last Updated on 02 Jan 2024
Guidance Recommendations
The Ministry of Health's Drug Advisory Committee has recommended:
Ferric carboxymaltose 500 mg/10 mL solution for injection/infusion for treating iron deficiency anaemia when oral iron preparations are ineffective or cannot be used.
Subsidy status
Ferric carboxymaltose 500 mg/10 mL solution for injection/infusion is recommended for inclusion on the MOH Standard Drug List (SDL) for the abovementioned indication.
SDL subsidy does not apply to ferric carboxymaltose 100 mg/2 mL injection.
Ferric carboxymaltose for iron deficiency anemia (Updated 2 Jan 2024) [PDF, 231 KB]
Ferric carboxymaltose for iron deficiency anaemia Plain English Summary (2 Sep 2019) [PDF, 33 KB]